• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植长期等待名单上的终末期肝病模型(MELD)例外情况及死亡新预测评分

MELD exceptions and new predictive score of death on long waiting lists for liver transplantation.

作者信息

Iacob S, Gheorghe L, Iacob R, Gheorghe C, Hrehoreţ D, Popescu I

机构信息

Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, Bucharest, Romania.

出版信息

Chirurgia (Bucur). 2009 May-Jun;104(3):267-73.

PMID:19601457
Abstract

BACKGROUND

Cirrhosis related complications, considered MELD exceptions, proved to add prognostic value to the MELD score in predicting waiting list mortality.

AIM

To identify the predictive value for death on a long waiting list (WL) for the complications of liver disease.

METHODS

During 2004-2007, 372 consecutive adult patients were listed for liver transplantation (LT). To identify the potential predictors of patient death, univariate and multivariate Cox's proportional hazards regression model was used.

RESULTS

In the univariate survival analysis the following variables were significant: spontaneous bacterial peritonitis, refractory ascites, hyponatremia, hepatic encephalopathy, hepatorenal syndrome, initial and current MELD score, initial and current Child-Pugh score. The independent predictors of death on our WL were: refractory ascites (p=0.002) and hepatorenal syndrome (p=0.002). Based on a logistic regression analysis a new score has been developed: Score = 1/(1+ exp(-(-4.38 + 1.34 x Refractory ascites + 0.9 x Hepatorenal syndrome + 0.15 x Current MELD). The c-statistic for the new score for prediction of death on the WL was 0.85 compared to 0.80 for current MELD score.

CONCLUSION

Refractory ascites and hepatorenal syndrome should add valuable points to the current MELD in order to better prioritize for LT patients included on long WL.

ABBREVIATIONS

Liver transplantation (LT), Model for End-Stage Liver Disease (MELD), waiting list (WL), United Network for Organ Sharing (UNOS), standard deviation (SD), receiver operating characteristic (ROC), hepatitis B virus (HBV), hepatocellular carcinoma (HCC), positive predictive value (PPV), negative predictive value (NPV), Child-Turcotte-Pugh (CTP), hepatic venous pressure gradient (HVPG).

摘要

背景

肝硬化相关并发症被视为终末期肝病模型(MELD)的例外情况,已证明其在预测等待名单上的死亡率时可为MELD评分增加预后价值。

目的

确定肝病并发症对长期等待名单(WL)上患者死亡的预测价值。

方法

在2004年至2007年期间,372例连续的成年患者被列入肝移植(LT)等待名单。为了确定患者死亡的潜在预测因素,使用了单变量和多变量Cox比例风险回归模型。

结果

在单变量生存分析中,以下变量具有显著性:自发性细菌性腹膜炎、难治性腹水、低钠血症、肝性脑病、肝肾综合征、初始和当前MELD评分、初始和当前Child-Pugh评分。我们等待名单上患者死亡的独立预测因素为:难治性腹水(p = 0.002)和肝肾综合征(p = 0.002)。基于逻辑回归分析开发了一个新的评分:评分 = 1 /(1 + exp(-(-4.38 + 1.34×难治性腹水 + 0.9×肝肾综合征 + 0.15×当前MELD))。用于预测等待名单上患者死亡的新评分的c统计量为0.85,而当前MELD评分为0.80。

结论

难治性腹水和肝肾综合征应在当前MELD基础上增加有价值的分数,以便更好地对长期等待名单上的肝移植患者进行优先排序。

缩写

肝移植(LT)、终末期肝病模型(MELD)、等待名单(WL)、器官共享联合网络(UNOS)、标准差(SD)、受试者工作特征曲线(ROC)、乙型肝炎病毒(HBV)、肝细胞癌(HCC)、阳性预测值(PPV)、阴性预测值(NPV)、Child-Turcotte-Pugh(CTP)、肝静脉压力梯度(HVPG)

相似文献

1
MELD exceptions and new predictive score of death on long waiting lists for liver transplantation.肝移植长期等待名单上的终末期肝病模型(MELD)例外情况及死亡新预测评分
Chirurgia (Bucur). 2009 May-Jun;104(3):267-73.
2
Variation of the MELD score as a predictor of death on the waiting list for liver transplantation.终末期肝病模型(MELD)评分的变化作为肝移植等待名单上死亡的预测指标。
J Gastrointestin Liver Dis. 2007 Sep;16(3):267-72.
3
Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.终末期肝病模型(MELD)和 Child-Turcotte-Pugh(CTP)评分:预测死亡率和因医疗状况不佳而从肝移植等待名单中移除的能力。
Arch Iran Med. 2014 Feb;17(2):118-21.
4
Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?用于评估等待肝移植患者的终末期肝病模型(MELD)评分系统:比Child-Turcotte-Pugh(CTP)系统更好吗?
Transplant Proc. 2008 Jul-Aug;40(6):1906-9. doi: 10.1016/j.transproceed.2008.05.072.
5
Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.终末期肝病模型(MELD)在以色列是否有效?对肝移植等待名单死亡率的批判性分析。
Isr Med Assoc J. 2006 Sep;8(9):605-9.
6
Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.终末期肝病模型(DeltaMELD)评分随时间增加作为晚期肝硬化患者预后预测指标的评估:危险因素分析及与初始MELD和Child-Turcotte-Pugh评分的比较
J Hepatol. 2005 Jun;42(6):826-32. doi: 10.1016/j.jhep.2005.01.019. Epub 2005 Mar 31.
7
Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.终末期肝病模型和终末期肝病-钠评分可预测等待肝移植前及等待肝移植期间的死亡率。
Transplant Proc. 2012 Mar;44(2):389-92. doi: 10.1016/j.transproceed.2012.01.037.
8
Predictors of death on the waiting list for liver transplantation characterized by a long waiting time.以等待时间长为特征的肝移植等待名单上的死亡预测因素。
Transpl Int. 2005 May;18(5):572-6. doi: 10.1111/j.1432-2277.2005.00090.x.
9
The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.终末期肝病评分模型是人类免疫缺陷病毒1感染的终末期肝病患者最佳的预后因素:一项前瞻性队列研究。
Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735.
10
Survival before and after model for end-stage liver disease score introduction on the Brazilian liver transplant waiting list.巴西肝移植等待名单上引入终末期肝病模型评分前后的生存率。
Transplant Proc. 2010 Mar;42(2):412-6. doi: 10.1016/j.transproceed.2010.01.028.

引用本文的文献

1
Pre and post-liver transplant outcome of cirrhotic patients with acute on chronic liver failure.肝硬化合并慢加急性肝衰竭患者肝移植前后的结局
Medicine (Baltimore). 2020 Oct 30;99(44):e22419. doi: 10.1097/MD.0000000000022419.
2
Minimal Hepatic Encephalopathy in Indians: Psychometric Hepatic Encephalopathy Score and Inhibitory Control Test for Diagnosis and Rifaximin or Lactulose for Its Reversal.印度人群中的轻微肝性脑病:用于诊断的心理测量肝性脑病评分及抑制控制测试,以及用于逆转的利福昔明或乳果糖
J Clin Transl Hepatol. 2019 Dec 28;7(4):304-312. doi: 10.14218/JCTH.2017.00037. Epub 2019 Nov 27.
3
Is transarterial chemoembolization beneficial for patients with diffuse infiltrative hepatocellular carcinoma?
经动脉化疗栓塞术对弥漫性浸润性肝细胞癌患者有益吗?
Hepatol Int. 2013 Jun;7(2):676-82. doi: 10.1007/s12072-012-9392-1. Epub 2012 Jul 27.